|PODIUM Deadline :||Nov 08, 2023|
|PODIUM Acceptance Notice:||Jan 10, 2024|
|POSTER Deadline to receive response before EB Registration deadline:||Nov 08, 2023|
|POSTER Deadline to make program:||Jan 17, 2024|
ALERT: Continuing Medical Education (CME) Requirements
We are working under CME requirements for MSACL 2024 through the University of Nebraska Medical School (UNMC).
This requires that there are NO logos on ANY slides that are presented from the PODIUM as part of a Scientific Session. This includes logos of not-for-profit institutions.
You will be required to pre-submit your slides for review at least 4 weeks prior to the meeting (by February 19) . If you did not report a conflict of interest, you can make minor modification of your submitted slides and then upload them at the meeting. If you reported a conflict of interest, these need to be the final version.
Q: Why are we doing CME?
A: To attract more people who are clinicians and need this level of education credit in order to justify meeting attendance time and cost.
Abstract Structure Guidelines:
MSACL is soliciting abstracts for both oral and poster presentations under the topics of:
Following submission and confirmation you will be able to Edit or Delete your abstract via your Network Directory Profile.
Introduction to Cases in Clinical Mass Spectrometry :: Podium or Poster
MSACL is inviting clinical cases or case series wherein the use of mass spectrometry to improve the current standard of clinical management of disease states is demonstrated. Attendees of the clinical case track will learn to identify and appreciate how mass spectrometry enhances patient care and guides clinical practice. The clinical case track will feature unique cases in interactive case sessions. Each case will exemplify a teaching pearl in clinical medicine and/or mass spectrometry and underscore the growing relevance of mass spectrometry to clinical medicine.
The clinical case abstract track will highlight cases where the use of mass spectrometry guided or changed the discourse of disease diagnosis and/or management. Abstracts will typically focus on an index case but may also describe a series of cases where the use of mass spectrometry facilitated and improved clinical management. The abstract should be structured with the following headings –Case Description, Background, MS Methods and Results, Discussion and Conclusion. The abstract may contain description of one or more specific cases and describe how mass spectrometry was leveraged to (a) improve current standard of clinical management (b) guide appropriate pharmacotherapy and/or treatment response, (c) identify previously unidentified etiology of disease, (d) diagnose toxicity, (e) differentiate disease states, (f) improve or change clinical outcome(s).
The Troubleshooting Forum has been created to provide a setting for discussion between LC-MSMS users working in clinical diagnostics. If you've had an LC-MSMS problem that has either been resolved with troubleshooting techniques, or is still in the process of resolution - this is an opportunity to share your experience with other clinical laboratory users. The more resolution needed the better. Simple or complex, method development, method validation or production - all types of troubleshooting cases are needed. If you learned something from it, the chances are someone else can learn something as well. The intent is to stimulate discussion and to propagate expertise and solutions on those aspects of the mass spectrometry experience that rarely see daylight ... when everything goes horribly wrong. This is not about being perfect, or even close. Come to learn, or come to share. Or both. One or more Troubleshooting Poster Rounds will be scheduled in which a team of experienced users (and interested attendees) will visit posters to listen to a brief summary by the presenter, and then discuss the case and provide suggestions. If you want your poster to be included in Troubleshooting Poster Rounds, select the Troubleshooting Poster Rounds topic when you submit your abstract.
(1) Content must be vendor neutral.
(2) There must be a strong point/experience to get across that is also vendor neutral (i.e. would benefit everyone regardless of the platform they use).
(3) No generic troubleshooting (i.e., autosampler problems, pump problems, most commonly encountered problems from the hotline, etc.).
TROUBLESHOOTING BONUS: Troubleshooting Abstracts do not count towards your abstract count. You can submit your own research AND a Troubleshooting abstract.
The Review Process:
All submitted abstracts are reviewed by the Steering Committee for scientific merit and appropriateness of content. Abstracts submitted for a podium presentation, but which are not chosen for an oral presentation will automatically be considered for poster contention.
The presenting author/person assumes full responsibility of the content of the abstract with all co-authors aware of this content. Please note that any material you submit and/or present including, but not limited to, your biography, summary and abstract may be used on the MSACL website and/or in conference materials.